Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
作者全名:"Xie, Xiang-ting; Zhang, Yan-fang; Zhang, Ying; Zeng, Han-qing; Deng, Jian-chuan; Zhou, Kang; Chen, Lin; Luo, Yun; Lou, Shi-feng"
作者地址:"[Xie, Xiang-ting; Zhang, Yan-fang; Zhang, Ying; Zeng, Han-qing; Deng, Jian-chuan; Zhou, Kang; Chen, Lin; Luo, Yun; Lou, Shi-feng] Chongqing Med Univ, Dept Hematol, Affiliated Hosp 2, 288 Tian Wen Rd, Chongqing 400010, Peoples R China"
通信作者:"Luo, Y (通讯作者),Chongqing Med Univ, Dept Hematol, Affiliated Hosp 2, 288 Tian Wen Rd, Chongqing 400010, Peoples R China."
来源:INTERNATIONAL IMMUNOPHARMACOLOGY
ESI学科分类:PHARMACOLOGY & TOXICOLOGY
WOS号:WOS:001037661700001
JCR分区:Q1
影响因子:4.8
年份:2023
卷号:121
期号:
开始页:
结束页:
文献类型:Article
关键词:BK virus; Hematopoietic stem cell transplantation; Risk factors; Prognosis
摘要:"Background: BK virus-associated hemorrhagic cystitis (BKV-HC) is a serious complication after allogeneic he-matopoietic stem cell transplantation (allo-HSCT). It can cause morbidity and may increase treatment-related mortality. Previous studies showed that the occurrence of BKV-HC was related to various factors. However, there are still many controversial factors. It is not clear whether BKV-HC will affect the long-term prognosis of patients. Objective: We aimed to identify risk factors for BKV-HC after allo-HSCT and evaluate the effect of BKV-HC on overall survival (OS) and progression-free survival (PFS) of patients. Study Design: We retrospectively analyzed the clinical data of 93 patients who underwent allo-HSCT. Univariate and multivariate analysis were used to identify risk factors for BKV-HC. The Kaplan-Meier method was used to estimate OS and PFS. A difference was considered statistically significant if P < 0.05. Results: A total of 24 patients developed BKV-HC. The median occurrence time of BKV-HC was 30 (range:8-89) days after transplantation, and the median duration was 25.5 (range:6-50) days. Multivariate logistic regression analysis indicated that peripheral blood lymphocyte count <1 x 109/L before conditioning (OR = 4.705, P = 0.007) and haploidentical transplantation (OR = 13.161, P = 0.018) were independent risk factors for BKV-HC. The 3-year OS rate was 85.9% (95%CI:62.1%-95.2%) in the BKV-HC group and 73.1% (95%CI: 58.2%-88.0%) in the non-BKV-HC group. There was no significant difference between the two groups (P = 0.516). The 3-year PFS rate was 76.3% (95%CI: 57.9%-94.7%) in the BKV-HC group and 58.1% (95%CI: 39.5%-76.7%) in the non-BKV-HC group. There was no significant difference in the two groups (P = 0.459). The severity of BKV-HC was not related to the OS and PFS of the patients (P value was 0.816 and 0.501, respectively). Conclusion: Haploidentical transplantation and decreased peripheral blood lymphocyte count before conditioning increased the risk of BKV-HC after allo-HSCT. The occurrence of BKV-HC after allo-HSCT and the severity of which did not affect OS and PFS of the patients."
基金机构:
基金资助正文: